(ANEB) Anebulo - Performance -35.1% in 12m
ANEB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-80.90%
#138 in Peer-Group
Rel. Strength
14.19%
#6586 in Stock-Universe
Total Return 12m
-35.14%
#109 in Peer-Group
Total Return 5y
-76.34%
#90 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.08 USD |
| 52 Week Low | 0.94 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.43 |
| Buy/Sell Signal +-5 | -2.11 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ANEB (-35.1%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ANEB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ANEB
| Total Return (including Dividends) | ANEB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 60.00% | 3.36% | 5.25% |
| 3 Months | 64.71% | 15.73% | 24.13% |
| 12 Months | -35.14% | -7.02% | 14.15% |
| 5 Years | -76.34% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ANEB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 79.3% | 4.4% | 81% |
| 3 Months | 73.9% | 78.8% | 96.9% |
| 12 Months | -82.7% | -85.8% | 44.9% |
| 5 Years | -91.7% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th97.00 | 54.81% | 52.02% |
| 3 Month | %th84.50 | 42.32% | 32.69% |
| 12 Month | %th45.50 | -30.23% | -43.18% |
| 5 Years | %th56.50 | -64.60% | -84.96% |
FAQs
Does Anebulo (ANEB) outperform the market?
No,
over the last 12 months ANEB made -35.14%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ANEB made 64.71%, while XBI made 15.73%.
Performance Comparison ANEB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ANEB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 13.4% | 54.8% | -2% | -49% |
| US NASDAQ 100 | QQQ | 13.6% | 54.7% | -2.6% | -48% |
| German DAX 40 | DAX | 15.5% | 61.4% | -14.1% | -64% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 13.5% | 56.8% | -5.4% | -55% |
| Hongkong Hang Seng | HSI | 13.8% | 53.9% | -21.4% | -74% |
| India NIFTY 50 | INDA | 15.2% | 56.5% | -2.3% | -34% |
| Brasil Bovespa | EWZ | 10.9% | 51.2% | -27% | -45% |
ANEB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 14.7% | 54.1% | -6.1% | -60% |
| Consumer Discretionary | XLY | 13.9% | 56.8% | 5.7% | -53% |
| Consumer Staples | XLP | 13.1% | 59.4% | -3.6% | -44% |
| Energy | XLE | 13% | 52.9% | 2.2% | -35% |
| Financial | XLF | 12.7% | 54.9% | -6.9% | -65% |
| Health Care | XLV | 13.9% | 57.9% | 5.4% | -31% |
| Industrial | XLI | 13.3% | 55.8% | -9.8% | -60% |
| Materials | XLB | 11.1% | 55.7% | -6.5% | -41% |
| Real Estate | XLRE | 13.4% | 59% | -1.7% | -48% |
| Technology | XLK | 12.6% | 51.3% | -4.3% | -46% |
| Utilities | XLU | 14.4% | 58.2% | -5.2% | -58% |
| Aerospace & Defense | XAR | 15.5% | 52.9% | -20.5% | -84% |
| Biotech | XBI | 12.4% | 56.6% | 11.3% | -28% |
| Homebuilder | XHB | 10.9% | 53% | 5.2% | -41% |
| Retail | XRT | 10.8% | 55% | 2.4% | -46% |
ANEB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 12.5% | 51.6% | 6.44% | -28% |
| Natural Gas | UNG | 22.9% | 69.8% | 14.8% | -33% |
| Gold | GLD | 13.1% | 61.2% | -22.6% | -74% |
| Silver | SLV | 12.3% | 53.1% | -19.3% | -53% |
| Copper | CPER | 14.3% | 55.4% | -19% | -46% |
ANEB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 15.2% | 59% | 1.5% | -33% |
| iShares High Yield Corp. Bond | HYG | 14.6% | 58.4% | -0.9% | -45% |